234 related articles for article (PubMed ID: 8349826)
1. 39-kD protein inhibits tissue-type plasminogen activator clearance in vivo.
Warshawsky I; Bu G; Schwartz AL
J Clin Invest; 1993 Aug; 92(2):937-44. PubMed ID: 8349826
[TBL] [Abstract][Full Text] [Related]
2. Two receptor systems are involved in the plasma clearance of tissue-type plasminogen activator (t-PA) in vivo.
Narita M; Bu G; Herz J; Schwartz AL
J Clin Invest; 1995 Aug; 96(2):1164-8. PubMed ID: 7635954
[TBL] [Abstract][Full Text] [Related]
3. Low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor is an hepatic receptor for tissue-type plasminogen activator.
Bu G; Williams S; Strickland DK; Schwartz AL
Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7427-31. PubMed ID: 1502154
[TBL] [Abstract][Full Text] [Related]
4. Receptor-mediated endocytosis of tissue-type plasminogen activator by low density lipoprotein receptor-related protein on human hepatoma HepG2 cells.
Bu G; Maksymovitch EA; Schwartz AL
J Biol Chem; 1993 Jun; 268(17):13002-9. PubMed ID: 8389767
[TBL] [Abstract][Full Text] [Related]
5. Studies on the effect of fucosylated and non-fucosylated finger/growth-factor constructs on the clearance of tissue-type plasminogen activator mediated by the low-density-lipoprotein-receptor-related protein.
Camani C; Gavin O; Bertossa C; Samatani E; Kruithof EK
Eur J Biochem; 1998 Feb; 251(3):804-11. PubMed ID: 9490055
[TBL] [Abstract][Full Text] [Related]
6. Fibrinolytic activity of human mesothelial cells is counteracted by rapid uptake of tissue-type plasminogen activator.
Sitter T; Toet K; Quax P; Kooistra T
Kidney Int; 1999 Jan; 55(1):120-9. PubMed ID: 9893120
[TBL] [Abstract][Full Text] [Related]
7. The role of the low-density lipoprotein receptor-related protein (LRP) in the plasma clearance and liver uptake of recombinant single-chain urokinase-type plasminogen activator in rats.
van der Kaaden ME; Rijken DC; Kruijt JK; van Berkel TJ; Kuiper J
Thromb Haemost; 1997 Apr; 77(4):710-7. PubMed ID: 9134648
[TBL] [Abstract][Full Text] [Related]
8. Identification and partial characterization by chemical cross-linking of a binding protein for tissue-type plasminogen activator (t-PA) on rat hepatoma cells. A plasminogen activator inhibitor type 1-independent t-PA receptor.
Bu G; Morton PA; Schwartz AL
J Biol Chem; 1992 Aug; 267(22):15595-602. PubMed ID: 1322401
[TBL] [Abstract][Full Text] [Related]
9. The carboxy terminus of tissue factor pathway inhibitor is required for interacting with hepatoma cells in vitro and in vivo.
Warshawsky I; Bu G; Mast A; Saffitz JE; Broze GJ; Schwartz AL
J Clin Invest; 1995 Apr; 95(4):1773-81. PubMed ID: 7706485
[TBL] [Abstract][Full Text] [Related]
10. Interaction of a 39 kDa protein with the low-density-lipoprotein-receptor-related protein (LRP) on rat hepatoma cells.
Iadonato SP; Bu G; Maksymovitch EA; Schwartz AL
Biochem J; 1993 Dec; 296 ( Pt 3)(Pt 3):867-75. PubMed ID: 8280086
[TBL] [Abstract][Full Text] [Related]
11. The 39-kDa protein regulates LRP activity in cultured endothelial and smooth muscle cells.
Warshawsky I; Schwartz AL
Eur J Cell Biol; 1996 Feb; 69(2):156-65. PubMed ID: 8907616
[TBL] [Abstract][Full Text] [Related]
12. Low density lipoprotein receptor-related protein is necessary for the internalization of both tissue-type plasminogen activator-inhibitor complexes and free tissue-type plasminogen activator.
Orth K; Willnow T; Herz J; Gething MJ; Sambrook J
J Biol Chem; 1994 Aug; 269(33):21117-22. PubMed ID: 8063731
[TBL] [Abstract][Full Text] [Related]
13. Clearance of tissue plasminogen activator by mannose and galactose receptors in the liver.
Smedsrød B; Einarsson M
Thromb Haemost; 1990 Feb; 63(1):60-6. PubMed ID: 2160132
[TBL] [Abstract][Full Text] [Related]
14. Pregnancy zone protein-tissue-type plasminogen activator complexes bind to low-density lipoprotein receptor-related protein (LRP).
Sánchez MC; Chiabrando GA; Vides MA
Arch Biochem Biophys; 2001 May; 389(2):218-22. PubMed ID: 11339811
[TBL] [Abstract][Full Text] [Related]
15. Native and non-glycosylated recombinant single-chain urokinase-type plasminogen activator are recognized by different receptor systems on rat parenchymal liver cells.
van der Kaaden ME; Rijken DC; Groeneveld E; van Berkel TJ; Kuiper J
Thromb Haemost; 1995 Aug; 74(2):722-9. PubMed ID: 8585013
[TBL] [Abstract][Full Text] [Related]
16. Antagonists of the mannose receptor and the LDL receptor-related protein dramatically delay the clearance of tissue plasminogen activator.
Biessen EA; van Teijlingen M; Vietsch H; Barrett-Bergshoeff MM; Bijsterbosch MK; Rijken DC; van Berkel TJ; Kuiper J
Circulation; 1997 Jan; 95(1):46-52. PubMed ID: 8994415
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic and distribution analysis of variant forms of tissue-type plasminogen activator with prolonged clearance in rat.
Larsen GR; Metzger M; Henson K; Blue Y; Horgan P
Blood; 1989 May; 73(7):1842-50. PubMed ID: 2496774
[TBL] [Abstract][Full Text] [Related]
18. Uptake, internalization and degradation of the novel plasminogen activator reteplase (BM 06.022) in the rat.
Kuiper J; van de Bilt H; Martin U; van Berkel TJ
Thromb Haemost; 1995 Dec; 74(6):1501-10. PubMed ID: 8772228
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the interaction both in vitro and in vivo of tissue-type plasminogen activator (t-PA) with rat liver cells. Effects of monoclonal antibodies to t-PA.
Otter M; Kuiper J; Bos R; Rijken DC; van Berkel TJ
Biochem J; 1992 Jun; 284 ( Pt 2)(Pt 2):545-50. PubMed ID: 1318035
[TBL] [Abstract][Full Text] [Related]
20. Identification of domains on the 39-kDa protein that inhibit the binding of ligands to the low density lipoprotein receptor-related protein.
Warshawsky I; Bu G; Schwartz AL
J Biol Chem; 1993 Oct; 268(29):22046-54. PubMed ID: 7691821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
